Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia (2024)
- Authors:
- Autor USP: REGO, EDUARDO MAGALHÃES - FM
- Unidade: FM
- DOI: 10.1182/blood.2024023890
- Subjects: LEUCEMIA; ANTINEOPLÁSICOS; SOBREVIDA
- Agências de fomento:
- Language: Inglês
- Sustainable Development Goals (GDS):
03. Good health and well-being
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
KOURY, Luisa Correa de Araujo et al. Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia. Blood, v. 144, n. 12, p. 1257-1270, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/79458. Acesso em: 12 jan. 2026. -
APA
Koury, L. C. de A., Kim, H. T., Undurraga, M. S., Navarro-cabrera, J. R., Salinas, V., Muxi, P., et al. (2024). Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia. Blood, 144( 12), 1257-1270. doi:10.1182/blood.2024023890 -
NLM
Koury LC de A, Kim HT, Undurraga MS, Navarro-cabrera JR, Salinas V, Muxi P, Melo RAM, Gloria AB, Pagnano K, Rego EM. Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia [Internet]. Blood. 2024 ; 144( 12): 1257-1270.[citado 2026 jan. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/79458 -
Vancouver
Koury LC de A, Kim HT, Undurraga MS, Navarro-cabrera JR, Salinas V, Muxi P, Melo RAM, Gloria AB, Pagnano K, Rego EM. Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia [Internet]. Blood. 2024 ; 144( 12): 1257-1270.[citado 2026 jan. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/79458 - Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
- Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR'alfa', PLZF/RAR'alfa' or NPM/RAR'alfa'
- Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL
- Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia
- Do paradigma molecular ao impacto no prognóstico: uma visão da leucemia promielocítica aguda
- Relevância da estratificação prognóstica na Doença de Hodgkin
- Transplante de medula óssea autólogo em amiloidose primária: relato de caso
- In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR'alfa' blockade in the pathogenesis of acute promyelocytic leukemia
- Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita
- Dyskeratosis congenita in mice deficient in ribosomal RNA modification
Informações sobre o DOI: 10.1182/blood.2024023890 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
